Abstracts tagged "DMARDs and hepatitis"

Abstract Number: 1645 • ACR/ARHP Annual Meeting 2012
Combination of Isoniazid for Latent Tuberculosis with Traditional and/or Biologic Disease Modifying Anti-Rheumatic Drugs Is Well Tolerated in Patients with Rheumatic Diseases
Dilrukshie Cooray¹, Saleem A. Waraich², Andrew Phan¹, Rosalinda C. Moran¹ and George A. Karpouzas¹, ¹Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, ²Placentia, CA
Background/Purpose: Patients with rheumatic diseases (RD) are typically treated with conventional and /or biologic disease modifying anti-rheumatic drugs (DMARD's) including tumor necrosis factor inhibitors (TNFi). …